These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39193812)

  • 1. Von Willebrand factor in inflammation and heart failure: beyond thromboembolic and bleeding risk.
    Ministrini S; Tirandi A
    Eur Heart J; 2024 Oct; 45(37):3868-3870. PubMed ID: 39193812
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand factor levels and congestive heart failure.
    Ariad S; Dvilansky A; Sobel R; Nathan I
    J Intern Med; 1991 Jun; 229(6):557-8. PubMed ID: 1878061
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.
    Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O
    J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
    Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
    Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic stenosis, von Willebrand factor, and bleeding.
    Sadler JE
    N Engl J Med; 2003 Jul; 349(4):323-5. PubMed ID: 12878737
    [No Abstract]   [Full Text] [Related]  

  • 9. A new spin on acquired von Willebrand factor deficiency during continuous-flow left ventricular assist device support.
    Toole JM
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):289-90. PubMed ID: 25312230
    [No Abstract]   [Full Text] [Related]  

  • 10. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand syndrome in aortic stenosis.
    Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
    N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
    Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of HeartMate II Patients Despite Cessation of Anticoagulation　- Outcomes and Hemostatic Analysis.
    Zayat R; Khattab MA; Grottke O; Honickel M; Goetzenich A; Moza A; Stoppe C; Autschbach R; Tewarie L
    Circ J; 2018 Apr; 82(5):1309-1318. PubMed ID: 29237991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic stenosis, von Willebrand factor, and bleeding.
    Hansen PR; Hassager C
    N Engl J Med; 2003 Oct; 349(18):1773-4; author reply 1773-4. PubMed ID: 14596230
    [No Abstract]   [Full Text] [Related]  

  • 17. The bleeding tendency in patients with low von Willebrand factor and type 1 phenotype is greater in the presence of impaired collagen-induced platelet aggregation.
    Weiss HJ
    J Thromb Haemost; 2004 Jan; 2(1):198-9. PubMed ID: 14717988
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices.
    Tscharre M; Wittmann F; Kitzmantl D; Schlöglhofer T; Cichra P; Lee S; Eichelberger B; Wadowski PP; Laufer G; Wiedemann D; Panzer S; Zimpfer D; Gremmel T
    Thromb Haemost; 2023 Mar; 123(3):336-346. PubMed ID: 36402132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor activity and activated partial thromboplastin time as proxy biomarkers for coagulopathies in women with menorrhagia in Zambia: a case-control study.
    Munsanje MM; Kaile T; Kowa S; Sinkala M; Simakando M; Ndhlovu J; Chiluba BC
    Pan Afr Med J; 2021; 39():13. PubMed ID: 34394804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor VIII and von Willebrand factor (aFVIII/VWF) deficiency and hypothyroidism in a case with hypopituitarism.
    Oliveira MC; Kramer CK; Marroni CP; Leães CG; Viana L; Roithman S; Schmaedecke A; Pereira-Lima JF
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):107-9. PubMed ID: 18550587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.